Utah Code 26B-4-212. Institutional review board — Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product
Current as of: 2024 | Check for updates
|
Other versions
(1) As used in this section:
Terms Used In Utah Code 26B-4-212
- Cannabis: means marijuana. See Utah Code 26B-4-201
- Cannabis Research Review Board: means the Cannabis Research Review Board created in Section
26B-1-420 . See Utah Code 26B-4-201 - Department: means the Department of Health and Human Services. See Utah Code 26B-4-201
- Person: means :(24)(a) an individual;(24)(b) an association;(24)(c) an institution;(24)(d) a corporation;(24)(e) a company;(24)(f) a trust;(24)(g) a limited liability company;(24)(h) a partnership;(24)(i) a political subdivision;(24)(j) a government office, department, division, bureau, or other body of government; and(24)(k) any other organization or entity. See Utah Code 68-3-12.5
- Process: means a writ or summons issued in the course of a judicial proceeding. See Utah Code 68-3-12.5
- State: when applied to the different parts of the United States, includes a state, district, or territory of the United States. See Utah Code 68-3-12.5
- United States: includes each state, district, and territory of the United States of America. See Utah Code 68-3-12.5
(1)(a) “Approved study” means a medical research study:(1)(a)(i) the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and(1)(a)(ii) that is approved by an IRB.(1)(b) “Board” means the Cannabis Research Review Board created in Section 26B-1-420.(1)(c) “Cannabinoid product” means the same as that term is defined in Section 58-37-3.6.(1)(d) “Cannabis” means the same as that term is defined in Section 58-37-3.6.(1)(e) “Expanded cannabinoid product” means the same as that term is defined in Section 58-37-3.6.(1)(f) “Institutional review board” or “IRB” means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.
(2) A person conducting an approved study may, for the purposes of the study:
(2)(a) process a cannabinoid product or an expanded cannabinoid product;
(2)(b) possess a cannabinoid product or an expanded cannabinoid product; and
(2)(c) administer a cannabinoid product, or an expanded cannabinoid product to an individual in accordance with the approved study.
(3) A person conducting an approved study may:
(3)(a) import cannabis, a cannabinoid product, or an expanded cannabinoid product from another state if:
(3)(a)(i) the importation complies with federal law; and
(3)(a)(ii) the person uses the cannabis, cannabinoid product, or expanded cannabinoid product in accordance with the approved study; or
(3)(b) obtain cannabis, a cannabinoid product, or an expanded cannabinoid product from the National Institute on Drug Abuse.
(4) A person conducting an approved study may distribute cannabis, a cannabinoid product, or an expanded cannabinoid product outside the state if:
(4)(a) the distribution complies with federal law; and
(4)(b) the distribution is for the purposes of, and in accordance with, the approved study.